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Neurodegeneration with brain iron accumulation (NBIA) comprises a group of neurodegenerative disorders char-
acterized by high brain content of iron and presence of axonal spheroids. Mutations in the PANK2 gene, which
encodes pantothenate kinase 2, underlie an autosomal recessive inborn error of coenzyme A metabolism, called
pantothenate kinase-associated neurodegeneration (PKAN). PKAN is characterized by dystonia, dysarthria, rigid-
ity and pigmentary retinal degeneration. The pathogenesis of this disorder is poorly understood and, although
PANK2 is a mitochondrial protein, perturbations in mitochondrial bioenergetics have not been reported. A
knock-out (KO) mouse model of PKAN exhibits retinal degeneration and azoospermia, but lacks any neurological
phenotype. The absence of a clinical phenotype has partially been explained by the different cellular localization
of the human and murine PANK2 proteins. Here we demonstrate that the mouse Pank2 protein localizes to mito-
chondria, similar to its human orthologue. Moreover, we show that Pank2-defective neurons derived from KO
mice have an altered mitochondrial membrane potential, a defect further corroborated by the observations of
swollen mitochondria at the ultra-structural level and by the presence of defective respiration.
INTRODUCTION
Pantothenate kinase-associated neurodegeneration (PKAN) is
the main disorder of a nosological family termed neurodegen-
eration with brain iron accumulation (NBIA), in which accu-
mulated iron can be visualized by radiological and
histopathological examination of the brain. PKAN is an
autosomal-recessive disorder characterized by progressive
motor impairment, associated with profound dystonia due to
mutations in the PANK2 gene. This gene codes for a
mitochondrial enzyme involved in the first regulatory step of
coenzyme A (CoA). CoA is synthesized from vitamin B5, or
pantothenate, and plays key roles in basic cellular functions
such as fatty acid metabolism, Krebs cycle and amino acid
synthesis. Pantothenate is taken up by endothelial cells via a
sodium-dependent multivitamin transporter and then passes
to the blood for delivery to the rest of the body (1). Pantothen-
ate is phosphorylated by pantothenate kinase, conjugated to
cysteine, decarboxylated, conjugated to an adenosyl group and
phosphorylated again to form CoA. These enzymatic activities
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have been detected in the cytosol and many in the mitochon-
drion, as well. An exclusively mitochondrial CoA synthetic
pathway has been proposed (2,3), although the cysteine
ligase and decarboxylation activities have not been detected
explicitly in the mitochondrion. PANK1, PANK2, PANK3
and PANK4 are four known isoforms of pantothenate
kinase. Probably PANK4 is not functional as pantothenate
kinase, but PANK1 and PANK3 are active in the
cytosol, while PANK2 is localized to and active in the mito-
chondrion (4).
The study of PANK2 function is complex, and efforts to
generate animal models of disease by knocking out the gene
in flies and mice have generated incomplete phenotypes,
lacking signs of neurodegeneration and/or of brain iron accu-
mulation (5,6). A PKAN model of Drosophila has a brain
phenotype characterized by the formation of vacuoles,
absence of iron accumulation, and Drosophila pantothenate
kinase isoforms do not strictly parallel those of humans (5).
In 2005, Pank2 null mice were generated (7), which showed
growth reduction, retinal degeneration and male infertility
due to azoospermia but no movement disorder or brain iron
accumulation, even after 18 months of age. In contrast, a pan-
tothenic acid-deficient diet was able to elicit a movement dis-
order and azoospermia in mice without evidence of iron
accumulation in brain (8).
These results have partially been explained by the sub-
cellular localization of the murine Pank2 protein, which was
reported to be predominately mitochondrial (9) or cytoplasmic
(10) by different groups. We performed experiments aimed at
demonstrating: (i) the sub-cellular localization of the murine
Pank2 protein and (ii) the presence of alterations in the func-
tion, regulation and structure of mitochondria in the available
KO mouse model. Our studies have demonstrated that Pank2
KO mice have mitochondrial dysfunction.
RESULTS
Mitochondrial localization of mouse Pank2 protein
Human and mouse PANK2 proteins show an identity of 90%,
although the mouse polypeptide does not have an N-terminal
extension, which is present in human PANK2. Software
tools predicting mitochondrial localization of proteins scored
high for the murine Pank2: Mitoprot (http://ihg.gsf.de/ihg/m
itoprot.html) gave a probability of 98%; Predotar (http://urgi.
versailles.inra.fr/predotar/predotar.html) of 72%, and TargetP
(http://www.cbs.dtu.dk/services/TargetP/) of 88%. To experi-
mentally verify the sub-cellular localization of the murine
protein, we performed western blot analysis using a commer-
cially available antibody (see Material and Methods) on total
homogenate, cytosol and mitochondria isolated from brain
and fibroblasts of wild-type (WT; Pank2+/+) and knock-out
(KO; Pank22/2) mice. We first tested specificity of the anti-
body by verifying its cross-reactivity with the Pank2 in vitro
translation product (not shown).
In the homogenate and cytosol derived from Pank2+/+ but
not from Pank22/2 brain, the antibody detected a faint band
of around 47 kDa, corresponding to the predicted molecular
weight of the murine Pank2 protein (Fig. 1A). A band of
higher intensity was present in mitochondria isolated from
Pank2+/+ mice, while it was completely absent in mitochon-
dria derived from Pank22/2 mice. These data indicated that
the Pank2 protein, which was detectable and enriched in the
mitochondrial fraction of wild-type mice, was missing in
Pank22/2 mice. To further determine in which sub-
mitochondrial compartment the Pank2 protein was present,
we further fractionated mitochondria derived from WT
mouse brain, into membranes, inter-membrane space, and
matrix, and we isolated mitoplasts. As shown in Figure 1B,
western blot analysis demonstrated that the mouse Pank2
protein was present into the mitochondrial inter-membrane
space and mitoplasts. However, by exposing mitoplasts to
the action of proteinase K (PK), the signal corresponding to
the Pank2 protein disappeared. On the contrary, signals corre-
sponding to proteins present in the mitochondrial matrix such
as Ethe1, or in the inner membrane such as Ndufa9 remained
protected from PK degradation. We obtained the same results
by fractionating mitochondria derived from mouse fibroblasts
(Fig. 1C). Altogether these data indicated that the mouse
Pank2 protein could be mainly located in the mitochondrial
inter-membrane space. In the mouse brain but not in fibro-
blasts, the protein was also barely detectable in the mitochon-
drial matrix.
Mitochondrial bioenergetics evaluation
In order to investigate mitochondrial bioenergetic status, we
performed spectrophotometric assays to measure the biochem-
ical activity of each single respiratory chain complex in differ-
ent tissue homogenates (muscle, brain and liver) derived from
Pank2+/+ and Pank22/2 mice. No alterations in the specific
activities of complex I, II, III, IV and V were observed (data
not shown).
We then evaluated respiration with microscale oxygraphy
on mitochondria isolated from mouse brain. This system
measures global oxygen consumption rate (OCR) and
extracellular acidification rate in intact cells and isolated
mitochondria.
According to Brand and Nicholls (11), and our group (12) in
intact cells, and by Rogers et al. (13) in isolated mitochondria,
the direct readout of cellular respiration can be used to define
relevant bioenergetic parameters, including (a) basal OCR
(OCR-B), after ADP addition (OCR-ADP), after oligomycin
addition (OCR-O).
We performed oxygen consumption measurement in three
different Pank2+/+ and Pank22/2 mice of 4 weeks of age. In
each experiment, we consistently observed reductions of
OCR-B, -ADP, –O, in mitochondria isolated from Pank22/2
brain when compared with Pank2+/+ (Fig. 2A).
In another set of experiments, we also added FCCP
(OCR-F) to measure uncoupler-stimulated respiration.
To compare the numerical results of the different experi-
ments, individual values were used to obtain z-scores of
OCR-B, -ADP, -O, -F (12).
For statistical analysis, we compared the z-scores obtained
in the Pank2+/+ versus Pank22/2 mitochondria (Fig. 2B).
The values obtained in the WT mitochondria were consistently
and significantly higher than those obtained in Pank22/2
mitochondria, for each of the mitochondrial respiratory
conditions.
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These differences were statistically significant as demon-
strated by an unpaired, two-sided Student’s t-test, assuming
unequal variance. Values for statistical significance were set
at P , 0.05.
We also evaluated the ATP content in cells derived from
three Pank2+/+ and three Pank22/2 mice.
We observed a reduced level of ATP in Pank22/2 derived
cells when compared with Pank2+/+ (Supplementary Mater-
ial, Fig. S1A), suggesting a lower capacity to produce ATP
in the absence of Pank2 protein. These data are in agreement
with the observation of a global reduction of the respiratory
capacity of intact mitochondria derived from Pank22/2
brains.
Parameters of oxidative stress
We measured the levels of protein carbonyl groups, a marker
of protein oxidation, by OxyBlot assay in the brain of three
Pank2+/+ and three Pank22/2 mice of 6 months of age.
The total level of carbonyls is similar between the two geno-
typic groups (Supplementary Material, Fig. S1B), although a
certain level of variability was noticed. We also performed
western blot analysis on the same samples with antibodies
specific to superoxide dismutase 1 and Catalase, but again
no significant differences were identified (not shown).
Mitochondrial morphology and integrity in peripheral
and central nervous systems
Since PKAN affects the central nervous system (CNS) in
humans, we sought to examine CNS neurons in mouse for evi-
dence of perturbed mitochondrial structure or function. We
derived neural precursors from hair bulge whisker (Supplemen-
tary Material, Fig. S2A) and sciatic nerve (Supplementary Ma-
terial, Fig. S2B) of Pank22/2 and Pank2+/+ mice and
subsequently differentiated these cells into neurons (seeMateri-
als and Methods). Cells showed typical morphology of neural
crest precursor (Supplementary Material, Fig. S2A), stained
positive for neural crest marker Nestin (Supplementary Mater-
ial, Fig. S2C and D) and were negative for glial fibrillary
acidic protein staining (Supplementary Material, Fig. S2E and
F). After induction with suitable culture medium, differentiated
neurons (Supplementary Material, Fig. S2G and H) expressing
the neuron-specific marker b-III-tubulin (Supplementary Ma-
terial, Fig. S2I–L) were obtained. The Mitotracker red, a mito-
chondrion specific dye, was used to stain both hair bulge- and
sciatic nerve-derived neurons obtained from Pank2+/+ and
Pank22/2mice.We observed that the dyewas exclusively loca-
lized into mitochondria in Pank2+/+ neurons (Fig. 3A–C)
while it was diffused throughout the cytoplasm and nucleus in
Pank22/2 neurons (Fig. 3B–D).
Figure 1. Mitochondrial localization of murine Pank2 protein. (A) Western blot analysis of different sub-cellular fractions derived from mouse brain: +/+
indicates Pank2+/+ animals; 2/2 indicates Pank22/2 animals. The same filter was incubated with anti-PANK2, anti-NDUFA9 and anti-SDH70 antibodies.
(B) Western blot analysis on different mitochondrial compartments isolated from WT mouse brain. (C) Western blot analysis on different mitochondrial com-
partments isolated from WT mouse fibroblasts. In (B and C) the filters were sequentially incubated with anti-PANK2, anti-NDUFA9, anti-SDH70 and anti-
ETHE1 antibodies.
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This difference was quantified by selecting a defined area cor-
responding to nucleus of neurons and by calculating the imageJ
parameter ‘RawIntDen’ (that is the sum of the values of the
pixels in the selected area) in WT and KO neurons. This param-
eter resulted in a 2.5-fold greater value in Pank22/2 neurons
when compared with Pank2+/+ neurons (Fig. 3G).
We reasoned that the type of Mitotracker used for the stain-
ing was also able to detect a qualitative defect in the mitochon-
drial membrane potential (DCm) (14).
To verify these data, we treated control fibroblasts with the
uncoupling agent valinomycin to induce the DCm loss. We
observed that the Mitotracker stains mitochondria in untreated
cells (Fig. 3E), while it spreads in the cytoplasm in fibroblasts
exposed to valinomycin (Fig. 3F).
To further corroborate these data we used 5,5′,6,6′-tetra-
chloro-1,1′,3,3′ tetraethylbenzimidazolylcarbocyanine iodide
(JC1) staining, which specifically detects variation in the mito-
chondrial membrane potential. The JC1 dye undergoes a re-
versible change in fluorescence emission from green to red
as mitochondrial membrane potential increases. Cells with
high membrane potential promote the formation of red fluores-
cent aggregates, while cells with low membrane potential
show a diffuse green fluorescence. As shown in Figure 4A,
C, E, WT neurons of different derivation presented red fluor-
escent aggregates, while KO neurons presented predominantly
with a diffuse green fluorescence (Fig. 4B–F). JC1 specificity
was tested by pre-treating WT neurons with valinomycin. As
reported in Supplementary Material, Figure S3, treated
neurons stain green fluorescent aggregates, whereas untreated
neurons showed red fluorescent aggregates.
To corroborate our observations, we performed electron
microscopic analysis on neurons in culture, which were
stained with JC1. Examination of semi-thin sections revealed
the presence of enlarged neurons with severe alteration in
the cytoplasm, containing abundant micro-vesicular structures,
mainly if not exclusively in Pank22/2 cells (Fig. 4H). Ultra-
structural investigation confirmed that, while the cytoplasm
of Pank2+/+ neurons exclusively showed endoplasmic reticu-
lum, vesicles and mitochondria with regular morphology
(Fig. 4I–K), Pank22/2 neurons contained lipid droplets, and
several swollen mitochondria with aberrant cristae and a com-
plete alteration of the matrix structure (Fig. 4J–L), together
with morphologically normal mitochondria.
We asked whether the same alteration observed in the per-
ipheral nerve and neurons was also present in the CNS of
Pank22/2 mice. To this aim, we derived neonatal hippocam-
pal neonatal neurons and we performed the JC1 staining ex-
periment. As reported in Figure 4E, a red fluorescent signal
was detected in neurons derived from Pank2+/+ mice,
whereas a green fluorescent signal (Fig. 4F) was exclusively
present in neurons derived from Pank22/2 animals.
Altogether, these data demonstrated that aberrant mitochon-
dria were present not only in neurons derived from the sciatic
nerve of adult animals, but also in neonatal hippocampal neurons.
Analysis of peripheral and CNSs
We analysed the sciatic nerve obtained from groups of three
Pank2+/+ and three Pank22/2 animals of 24 and 48 weeks
of age, respectively.
Examination of semithin sections, counterstained with Tolui-
dine Blue, revealed no obvious differences in myelinated fibre
density, in the absence of demyelinating features. However,
Pank22/2 nerve showed a mild reduction in large-caliber
fibre and some more prominent wallerian-like degenerations
compared with controls (Fig. 5A and B). Overall, no clear-cut
sign of progressive neuropathy was present, since no reduction
in myelinated fibres or increase in the number of degenerating
fibres has been detected (Fig. 5C and D).
Ultra-structural analysis of sciatic nerve of Pank22/2
animals confirmed the presence of occasional degenerating
fibres, and a normal representation of un-myelinated fibres
(Fig. 5E and F). However, a substantial number of myelinated
fibres (Fig. 6B–D), and occasionally un-myelinated axons and
Schwann cells, contained (Supplementary Material,
Fig. S4B–D) swollen mitochondria, characterized by alteration
of cristae and by the presence of multivescicolar bodies or
amorphous material, in the matrix (Fig. 6A–C and Supplemen-
tary Material, Fig. S4A–C). Aberrant mitochondria appear to
increase with age since in 48 week Pank22/2 old mice versus
24 week old mice (Fig. 6B) a greater number of swollen mito-
chondria with a profound alteration of the matrix were detected
(Fig. 6D).
We also analysed the basal ganglia of 48-week-old mice.
Electron microscopy demonstrated morphologically abnormal
mitochondrial cristae with enlarged cisternae, which were
Figure 2. Evaluation of mitochondrial bioenergetics status. (A) OCR in Pank2+/+ and Pank22/2 mouse brain mitochondria. Black, white and grey histograms
indicate OCR-B, -ADP and -O, respectively. Bars indicate the standard deviation (SD). ∗∗P , 0.01 (unpaired, two-tail Student’s t-test). (B) Analysis of OCR-B,
-ADP, -O and -F. The z-score values (dots) for OCR-B, -ADP, -O and -F are shown for Pank2+/+ versus Pank22/2. Data are expressed as the means (dots) and
95% confidence intervals, Confidence interval (bars). Student’s t-test for Pank2+/+ versus Pank22/2: diamond, P ¼ 1.0E207; square, P ¼ 1.3E204; triangle,
P ¼ 1.0E207; asterisk, P ¼ 1.2E209. Three Pank2+/+ and three Pank22/2 mice of 4-week-old were analysed.
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predominant in the Pank22/2 (Fig. 6F–H) when compared
with Pank2+/+ (Fig. 6E–G).
These data indicate the presence of defective mitochondria
in both the peripheral and CNSs in mice with defective Pank2.
DISCUSSION
We have demonstrated that the murine Pank2 protein is
mainly located in the mitochondrial inter-membrane space,
which is compatible with its role in CoA metabolism and
with its regulation in the presence of CoA at concentrations
found in mitochondrial matrix (10). Further investigation
using, for instance, immuno-electronmicroscopy is needed to
unequivocally establish this sub-mitochondrial localization.
This observation makes the Pank22/2 mouse model a
promising system to study pathophysiology of human
PKAN. In fact, although the mouse model does not recapitu-
late the clinical and neuropathological features of the human
condition (7), it could serve as a system in which to interrogate
the basic defect in mitochondrial function.
We did not detect the deficiency in the enzymatic activity of
anymitochondrial respiratory chain complex in different tissues
of Pank22/2 mice. However, recent observations indicate that
mitochondrial respiration is largely carried out by the fraction
of respiratory chain complexes that assemble together in super-
complexes forming functionally active units, called respira-
somes (15,16). Thus, the spectrophotometric measurement of
each respiratory complex activity does not necessarily reflect
the mitochondrial functional capacity in vivo. Microscale oxy-
graphy could overcome this limitation and in fact, using this ap-
proach, we detected a modification in the respiratory profile of
mitochondria derived from Pank22/2 when compared with
Pank2+/+ brains. Highly significant differences of OCR-B,
-ADP, -O and –F were obtained by statistical analysis of
either the single values or as overall values of Pank2+/+
versus Pank22/2 mitochondria, expressed as z-scores (Fig. 2).
Together, these results indicate that the absence of the Pank2
protein leads to a global failure of the mitochondrial bioenerget-
ic performance without affecting the function of any single re-
spiratory chain complex.
An interesting result of our study, strictly correlated with
the absence of Pank2 function, was the demonstration of alter-
ation in mitochondrial membrane potential in neurons derived
from sciatic nerve and hair bulge stem cells of adult mice. In
addition, the same alteration was also present in neonatal hip-
pocampal neurons, suggesting the presence of defective mito-
chondria in Pank22/2 mice since birth.
These results were confirmed by electron microscopy ana-
lysis on cultured neurons derived from Pank22/2 mice, in
which aberrant mitochondria with remodelled cristae were
present. Moreover, peripheral and CNSs examination of
Pank22/2 mice showed the presence of swollen mitochondria
with amorphous electron-dense inclusions and dysmorphic
cristae.
Recently, the characterization of a PKAN Drosophila model
demonstrated that impaired function of pantothenate kinase
induced a neurodegenerative phenotype with mitochondrial
dysfunction, decreased levels of CoA, increased protein oxida-
tion and reduced lifespan (17).
JC1 staining and electron microscopic analysis revealed
that, in contrast to WT flies, mitochondria of dPANK/fbl
mutants showed an alteration in the transmembrane potential,
were swollen and presented with altered cristae and ruptured
membranes (18). These observations are in agreement with
Figure 3. Mitochondrial morphology evaluated with the Mitotracker-red. (A)
Neurons derived from hair bulge from Pank2+/+ mice. (B) Neurons derived
from hair bulge from Pank22/2 mice. (C) Neurons derived from sciatic
nerve of Pank2+/+ mice. (D) Neurons derived from sciatic nerve of
Pank22/2 mice. (E) Control fibroblasts. (F) Control fibroblasts treated with
valinomycin. (G) Histogram reporting the quantification of Mitotracker diffu-
sion in Pank2+/+ and Pank22/2 neurons using the RawIntDen parameter (see
Materials and Methods). Bars indicated SD. ∗P ¼ 3.37E223 (unpaired,
two-tail Student’s t-test).
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our results in the nervous system of Pank22/2 mice in which
mitochondria are severely damaged.
In search for mechanisms underlying the alteration of mito-
chondria, we found a reduced level of ATP in Pank22/2
mice. Interestingly, we found that state 3 activity, which repre-
sent the maximum respiration rate in the presence of ADP, is
significantly decreased in mitochondria isolated from
Pank22/2 mice. It is tempting to speculate that the reduction
Figure 4. Membrane potential and electron microscopy in Pank2+/+ and Pank22/2 neurons. (A andB) JC1 staining of neurons derived from hair bulge. (C andD)
JC1 staining of neurons derived from sciatic nerve. (E andF) JC1 staining of neonatal neuron derived from hippocampus. Blue fluorescence indicates DAPI staining
of nuclei. Green fluorescence indicates an alteration in mitochondrial DC; red fluorescence indicates the preservation of a normal mitochondrial DC. (G and H)
Electronmicroscopy of neurons derived from sciatic nerve (semithin section ToluidinBlue). (I–L) Electronmicroscopy of neurons derived from sciatic nerve (ultra-
structure uranyl acetate and lead citrate). Normal appearing mitochondria in Pank2+/+ neurons (I–K) and few normal mitochondria in Pank22/2 neurons (black
arrows in J–L); aberrant mitochondria with disrupted matrix and cristae (red arrows in J–L); lipid filled vesicle (asterisk in J).
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in the respiration could be attributable to the severe alteration of
the cristae structure, which could prevent the respirasomes from
remaining functionally active.
We also investigated the presence of oxidative damage in
brains, but we did not find significant differences in oxidative
damage at least in 6-month-old Pank22/2 mice. As demon-
strated by other studies, mitochondrial membrane damage
contributes to the pathogenesis of many neurodegenerative
diseases (19,20).
Interestingly enough, a recent investigation of a KO mouse
model for the Pla2g6 gene, which is defective in a different
but related form of NBIA, revealed the presence of collapsed
mitochondria with degenerated inner membranes (21). Pla2g6
gene encodes a group VIA calcium-independent phospholip-
ase A2, an esterase that hydrolyzes the sn-2 ester bond in
phospholipids to yield free fatty acids and lysophospholipids
and which is involved in cardiolipin remodelling (22). Ana-
lysis of phospholipids and fatty acids revealed differences
between KO and WT mice. The vulnerability of mitochon-
drial inner membranes in Pla2g6 KO mice might be attribut-
able to increased production of reactive oxygen species (ROS)
(23) and a rich content of polyunsaturated fatty acids that can
Figure 5. Evaluation of neurodegeneration of peripheral nervous systems with optic and electron microscopy. Sciatic nerve semithin section (Toluidin Blue) of
(A) 24-week-old and (C) 48-week-old Pank2+/+ mice; (B) 24-week-old and (D) 48-week-old Pank22/2 mice. Fibre density is not clearly different, whereas the
axonal diameter seems to be reduced in Pank22/2. Electron micrographs of 48-week-old mice sciatic nerve in Pank2+/+ mice (E) and Pank22/2 mice (F). No
sign of un-myelinated fibre loss in the form of collagen pockets or denervated Schwann cells were evident; in Pank22/2 mice, some enlarged mitochondria were
detected (arrows in F).
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Figure 6. Electronmicroscopy of peripheral and CNS of 24- and 48-week-old animals. (A–C) Sciatic nerve ofPank2+/+mice show normalmitochondria (arrows).
(B–D) Sciatic nerve of Pank22/2 mice show swollen mitochondria with altered cristae (arrows). (E–G) Basal ganglia derived from 48-week-old Pank2+/+ mice
show normally shaped mitochondria. (F–H) Basal ganglia derived from 48-week-old Pank22/2 mice show altered cristae and enlarged cisternae.
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readily be peroxidized, such as linoleic acid in cardioli-
pin (22).
Alteration in cholesterol and lipid metabolism was also re-
cently demonstrated by a metabolomics investigation in a
group of PKAN patients (24). In this case, however, the alter-
ation was mainly due to a defective synthesis and not, as in the
case of PLA2G6, to the absence of a catabolic enzyme.
Irrespective of the anabolic (PANK2) or catabolic
(PLA2G6) role of these two mitochondrial proteins, a
common culprit in the pathogenesis of both neurodegenerative
diseases could be an altered lipid metabolism (25). Further
characterization of the lipid profile in Pank22/2 mice is in
progress to understand if and how alteration of this metabolic
pathway could be responsible for the observed mitochondrial
membranes modifications.
We demonstrated insufficient energy production and severe
mitochondrial dysfunction in the brain and peripheral nerve of
Pank22/2 mice, without increased oxidative stress or signs of
neurodegeneration. It is possible that mice can better tolerate
alterations in bioenergetics metabolism without suffering any
overt clinical manifestations because of the presence of com-
pensatory mechanisms. Few examples of mouse models of
mitochondrial disorders, which display a biochemical pheno-
type but do not present any clinical signs typical of the
human pathology, are described in the literature (26,27).
Although we clearly demonstrated mitochondrial dysfunc-
tion in Pank22/2 mice, we remain uncertain why neither
neurological signs typical of PKAN nor iron accumulation
occur in mice. However, our findings suggest that there
would be value in investigating bioenergetic competence and
ultra-structural abnormalities of mitochondria in PKAN
patients.
MATERIALS AND METHODS
Animals and diet
The use and care of animals followed the Italian Law D.L.
116/1992 and the EU directive 86/609/CEE. Animal studies
were approved in accordance with guidelines of the Italian
Ministry of Health: Project n. BT4/2011.
The JM129/SvJ–C57BL/6 Pank2+/2 mice used in this
study were the same as those generated in 2005 (7).
Animals were housed two or three per cage in a
temperature-controlled (218C) room with a 12 h light–dark
cycle and #60% relative humidity. Standard diet (DS, Muce-
dola, Italy) and water were given ad libitum.
Mitochondria isolation
Standard methods were used for the preparation of mitochon-
drial and post-mitochondrial fractions from mouse brain (28).
Brain was extracted and rinsed using cold homogenization
medium AT [0.075 M sucrose, 0.225 M mannitol, 1 mM ethyl-
ene glycol tetraacetic acid (EGTA), 0.01% bovine serum
albumin (BSA), pH 7.4]. The organ weighted was cut into
small pieces and washed to remove blood and connective
tissue. The brain was homogenized with 10–15 strokes
using a Dounce-type glass homogenizer with a manually
driven glass pestle, adding 5 ml of homogenization medium
AT per gram of the starting material. The tissue was centri-
fuged at low speed (1000g for 5 min at 48C) and the resulting
supernatant was transferred to a clean tube and spin at high
speed (9000g for 10 min at 48C). The supernatant obtained
from this centrifugation contained cytosol. To clean the mito-
chondrial pellet obtained, we resuspended it with 5 ml of
medium AT, transferred to 1.5 ml Eppendorf tubes and
washed to obtain a single pellet. The washed mitochondria
were resuspended in the appropriate volume of MAITE
medium (25 mM sucrose, 75 mM sorbitol, 100 mM KCl,
0.05 mM EDTA, 5 mM MgCl2, 10 mM Tris–HCl, 10 mM
H3PO4, pH 7.4). This fraction contained free mitochondria
and synaptosomes.
Mitochondria fractionation
Isolated mitochondria were resuspended in 100 ml of potas-
sium phosphate buffer [(PP) buffer, 20 mM, pH 7.8, KCl
150 mM] and sonicated 10 s for three times at 10 Amp. The
suspension was centrifuged at 164000g for 30 min at 48C.
Supernatant (mitochondrial matrix and inter-membrane
space) was collected, and pellet (mitochondrial membranes)
was resuspended in 100 ml of PP buffer.
Isolation and fractionation of mitoplasts
Isolated mitochondria were resuspended in 100 ml of hom-
ogenisation medium A. After quantification of protein with
Bradford method (Biorad), the sample was incubated for
5 min at 48C with Digitonin (Fluka) at a final concentration
of 0.18 mg for mg of protein. Digitonin was then diluted
with 10 volumes of medium A and the sample was centrifuged
at 12 000g for 10 min at 48C. Supernatant (inter-membrane
space) was collected, and pellet (mitoplasts) was resuspended
in 100 ml of PP buffer.
Mitoplasts were then sonicated 10 s for three times at
10 Amp. The suspension was centrifuged at 164000g for
30 min at 48C. Supernatant (mitochondrial matrix) was col-
lected and pellet (mitochondrial inner membrane) was resus-
pended in 100 ml of PP buffer.
Western blot analysis
Thirty micrograms of proteins were used for each sample in
denaturing sodium dodecyl sulphate–polyacrylamide gel elec-
trophoresis (SDS–PAGE). Western blot analysis was per-
formed as described (29), using the ECL-chemiluminescence
kit (Amersham).
Antibodies
The following mouse monoclonal antibodies were used:
anti-PANK2 (Origene) at 1:2000 dilution, anti-NADHdehydro-
genase ubiquinone 1 alpha subcomplex subunit 9 (NDUFA9)
(Invitrogen) at final concentration of 0.5 mg/ml and anti-Rieske
(Invitrogen) at a final concentration of 2 mg/ml, anti-SDH-70
(succinate dehydrogenase, subunit 70 kDa) (Invitrogen) at
1:5000 dilution. An anti-ethylmalonic encephalopathy 1 rabbit
polyclonal antibodywas used at 1:2000 dilution (30). Secondary
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anti-rabbit and anti-mouse antibodies were used at 1:10 000 and
1:7000 dilutions, respectively.
ATP and oxidative stress assays
ATPLite kit (PerkinElmer Life Sciences) was used to measure
ATP levels according to manufacturer’s instructions. This
method is based on mono-oxygenation of luciferin, catalyzed
by luciferase in the presence of Mg2+, ATP and oxygen,
resulting in a luminescent signal that is proportional to the
ATP concentration.
Oxidized proteins were detected using the Oxyblot Protein
Oxidation Detection Kit (Millipore) following the manufac-
turer’s instructions. Brain extracts were homogenized in
20 mM Tris–HCl, pH 7, 50 mM dithiothreitol in the presence
of anti-protease inhibitor cocktail tablet (Roche) and then deri-
vatized to 2,4-dinitrophenylhydrazone. One microgram of pro-
teins was loaded on 12% SDS–PAGE, blotted and incubated
with an anti-DPN antibody. The bound activity was revealed
by ECL Advance kit (Amersham).
Mitochondria membrane potential
Mitochondrial morphology was assessed after cell staining
with 10 nM Mitotracker CMX-Red (Invitrogen) for 30 min at
378C. Fluorescence was visualized with a digital imaging
system using an inverted epifluorescence microscope with
×63/1.4 oil objective (Nikon, Japan). Images were captured
with a back-illuminated Photometrics Cascade CCD camera
system (Crisel) and analysed with Metamorph acquisition/ana-
lysis software. Different diffusion of the mitotraker in the
neuron cytoplasm was quantified, calculating the parameter
‘RawIntdens’ of ImageJ software (http://rsbweb.nih.gov/ij/)
that is the sum of the values of the pixels in selected areas.
These data were calculated in 66 neurons (33 KO versus 33
WT) in three different experiments.
Detection of mitochondrial potential change was performed
using JC1 (Sigma, CS0390) staining kit according to manufac-
turer’ instructions.
Evaluation of bioenergetic profile
Measurements of oxygen consumption were performed on iso-
lated mitochondria derived from mouse brain using an XF96
Extracellular Flux Analyser (Seahorse Bioscience).
To rapidly isolate mitochondria, brains were obtained from
sacrificed mice and washed three times in ice-cold phosphate-
buffered saline (PBS), than homogenized with 15 strokes in a
glass-dounce homogenizer with 2 ml of hepes, EDTA, sucrose
(HES)–0.2% BSA (HEPES 5 mM, EDTA 1 mM, sucrose
250 mM, BSA 0.2%, pH 7.4).
The homogenate was centrifuged for 10 min 2000 rpm
(700g) at 48C, and the supernatant was collected in a new
tube, the pellet was resuspended in HES–0.2% BSA and cen-
trifuged for 10 min 2000 rpm at 48C.
The supernatant was collected and centrifuged for 15 min at
9000g and the supernatant was discarded; the pellet was resus-
pended in HES–0.2% BSA and centrifuged for 15 min
10 000 rpm and the supernatant was discarded.
The pellet containing mitochondria was resuspended in
HES–0.2% BSA and total protein (mg/ml) was determined
using Bradford Assay reagent (Bio-Rad).
As indicated by Rogers et al. (13), the WT and KO brain
mitochondria were seeded in an XF 96-well cell culture micro-
plate (Seahorse Bioscience) at a protein concentration of 8 mg/
well in 50 ml of MAS-1 1× (70 mM sucrose, 220 mM manni-
tol, 10 mM KH2PO4, 5 mM MgCl2, 2 mM HEPES, 1 mM
EGTA and 0.2% (w/v) fatty acid-free BSA, pH 7.2) supple-
mented with succinate, malate, glutamate and pyruvate
5 mM. The plate was centrifuged 2000g for 5 min at 48C,
130 ml of succinate, malate, glutamate and pyruvate 5 mM
were added and incubated at 378C without CO2 for 30 min
before starting the assay.
OCRwasmeasured under basal condition (OCR-B), and after
sequentially adding to each well 20 ml of ADP (OCR-ADP) and
22 ml of oligomycin (OCR-OL) to reach working concentra-
tions of 4 mM and 2.5 mM respectively. OCR was also measured
after addition of carbonyl cyanide 4-(trifluoromethoxy)
phenylhydrazone (FCCP), to evaluate the maximal respiratory
capacity.
The detailed protocol was as follows:
1′ Mixing
3′ Waiting
1′ Mixing
3′ Waiting
Basal OCR:
30′′ Mixing
3′ Recording
1′ Mixing
3′ Recording
30′′ Mixing
ADP addition through port A
1′ Mixing
3′ Recording
1′ Mixing
3′ Recording
1′ Mixing
Oligomycin addition through port B
30′′ Mixing
3′ Recording
1′ Mixing
3′ Recording
1′ Mixing
3′ Recording
Statistics
For individual experiments, data obtained from Pank2+/+ and
Pank22/2 mitochondria were calculated as the mean of the
replicates+ standard deviation (SD) and then compared with
unpaired two-tailed Student’s t-test. Although the measure-
ments obtained from the replicates for each sample were rela-
tively consistent in individual experiments, the values may
vary in different experiments performed in different days.
For this reason, we transformed each value of OCR-B,
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OCR-ADP, OCR-O and OCR-F into standard (z) scores, in
order to make the data of three different experiments compar-
able with each other and perform statistical analysis to the
entire collection of experimental values. In practice, for each
sample, the overall mean was subtracted from each measure,
and the result was divided by the overall SD of the experiment.
The resulting values indicate how many SD’s separate a given
observation from the reference value of the experiment.
Transformed data were then compared across samples and
across experiments by unpaired two-tailed Student’s t-test.
Results with P , 0.05 were considered statistically significant.
Electron microscopy analysis
Sciatic nerves samples from 24- and 48-week-old Pank2+/+
and Pank22/2 mice were surgically removed and fixed in glu-
taraledehyde 2.5% in phosphate buffer (pH ¼ 7.4), post-fixed
in aqueous solution of osmium tetroxide, dehydrated in
acetone and embedded in epoxy resin (SPURR, EM Sciences).
One-millimetre-thick sections were stained with Toluidine
Blue.
For ultra-structural analysis, sections of 90 nm were col-
lected on 200-mesh copper grids, positively stained with
uranyl acetate and lead citrate, and then analysed by transmis-
sion electron microscope (EM109 Zeiss) to evaluate the pres-
ence of possible alterations in axonal morphology, cell
membranes and mitochondria.
Sagittally spliced brains from 72-week-old Pank2+/+ and
Pank22/2 mice were fixed by immersion in 4% paraformalde-
hyde–PBS. After fixation, serial sagittal slides of #1 mm
thick were obtained. Selected areas of interest were sampled,
post-fixed in osmium tetroxide and embedded in Epon epoxy
resin. Thin sections (80–90 nm) were stained with uracyl
acetate and lead citrate and examined with a CM10 Philips
electron microscope.
Neurons derived from sciatic nerve were collected by gentle
scraping and fixed in glutaraledehyde 2.5% in phosphate
buffer (pH ¼ 7.4). Cells pellet was treated for ultra-structural
analyses as described above.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
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